GPRE Green Plains Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 1309402 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-19.1%
TTM net income YoY204.9%
TTM EPS YoY186.3%
Revenue 3-yr CAGR-19.6%
Net income 3-yr CAGR—
Margins
Gross margin21.1%
Operating margin10.7%
Net margin10.9%
FCF margin4.4%
EBITDA margin15.9%
Returns
ROE22.9%
ROA12.1%
ROIC (approx.)18.4%
Asset turnover1.11x
Leverage & solvency
Liabilities / assets44.7%
Debt / equity0.48x
Current ratio2.31x
Interest coverage5.76x
Cash quality & payout
Operating cash flow / net income0.58x
Accruals ratio5.1%
Payout ratio—
Capex / revenue1.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.09B | $2.46B |
| Cost of revenue | $1.95B | $2.33B |
| Gross profit | $136.93M | $130.45M |
| SG&A expense | $122.71M | $118.05M |
| Operating income | -$67.25M | -$47.46M |
| Interest expense | $76.67M | $33.09M |
| Pretax income | -$143.82M | -$71.30M |
| Income tax | -$51.75M | $6.21M |
| Net income | -$121.28M | -$82.50M |
| EBITDA | $31.19M | $43.13M |
| EPS (basic) | -1.80 | -1.29 |
| EPS (diluted) | -1.80 | -1.29 |
| Weighted avg. shares (diluted) | 67.50M | 63.80M |
| Balance sheet | ||
| Cash & equivalents | $182.32M | $209.40M |
| Receivables | $74.37M | $94.90M |
| Current assets | $522.54M | $569.03M |
| PP&E, net | $957.26M | $1.04B |
| Intangibles | $10.48M | $12.67M |
| Total assets | $1.58B | $1.78B |
| Current liabilities | $268.71M | $385.69M |
| Short-term debt | $3.92M | $2.12M |
| Long-term debt | $361.99M | $432.46M |
| Total debt | $365.92M | $434.58M |
| Total liabilities | $812.92M | $907.64M |
| Shareholders' equity | $766.25M | $865.22M |
| Net debt | $183.60M | $225.18M |
| Shares outstanding | 69.83M | 64.71M |
| Cash flow statement | ||
| Operating cash flow | $110.86M | -$29.96M |
| Capital expenditure | $37.20M | $95.08M |
| Free cash flow | $73.67M | -$125.05M |
| Investing cash flow | $162.13M | -$62.05M |
| Financing cash flow | -$252.26M | -$77.35M |
| Depreciation & amortization | $98.43M | $90.59M |
| Stock-based compensation | $17.12M | $8.27M |
| Dividends paid | $721,000 | $5.17M |
| Share buybacks | $30.00M | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.